Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MAINZ BIOMED B.V.
No Price
17.08.2026 16:06
Current Prices from MAINZ BIOMED B.V.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
IEX
QUCY
USD
17.08.2026 16:06
1,44 USD
-0,04 USD
-2,70 %
NASDAQ
QUCY
USD
17.08.2026 15:59
1,44 USD
-0,04 USD
-3,04 %
Company Profile for MAINZ BIOMED B.V. Share
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
